Close Menu

NEW YORK – Researchers at the MD Anderson Cancer Center, Loyola University Chicago Stritch School of Medicine, and elsewhere have determined that a breast cancer recurrence score provided by the Genomic Health 21-gene expression assay OncotypeDX may provide valuable prognostic information on locoregional disease recurrence that may aid in decision-making about radiotherapy for postmenopausal women with node-positive, estrogen receptor- or progesterone receptor-positive breast cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.